Graminex®, L.L.C. voltooit klinische proef met Graminex® Flower Pollen Extract, gericht op urine-incontinentie bij vrouwen met positieve resultaten.
DESHLER, Ohio–(BUSINESS WIRE)– Graminex®, L.L.C. is verheugd aan te kondigen dat het een klinische studie met Graminex® Flower Pollen Extract voor urine-incontinentie en urinegezondheid bij vrouwen met positieve resultaten heeft afgerond. Deze studie werd uitgevoerd als een gerandomiseerde, dubbelblinde, placebo-gecontroleerde studie om de effectiviteit van Graminex® bloempollenextracten te onderzoeken bij 190 gezonde vrouwen met urine-incontinentie. Voorlopige analyse gaf aan dat er significante verbeteringen werden gevonden in de Graminex® Flower Pollen Extract-studiegroep voor meervoudige indicatoren voor de kwaliteit van leven van urine-incontinentie.
Al vele jaren worden extracten van stuifmeel van bloemen onderzocht op symptomen van de menopauze bij vrouwen. Onlangs heeft Graminex® voordelen ontdekt in de meer specifieke categorie van urine-incontinentie voor vrouwen, met name door stress veroorzaakte urgentie. Urine-incontinentie is meer uitgesproken bij postpartum vrouwen en tijdens de menopauze.
Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.
DESHLER, Ohio–(BUSINESS WIRE)– Graminex®, L.L.C. is pleased to announce it has completed a clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health with positive results. This study was conducted as a randomized, double-blind, placebo-controlled, study to investigate the effectiveness of Graminex® Flower Pollen Extracts in 190 healthy women with urinary incontinence. Preliminary analysis indicated significant improvements were found in the Graminex® Flower Pollen Extract study group for multiple urinary incontinence quality of life indicators.
For many years flower pollen extracts have been studied for women’s menopause symptoms. Recently, Graminex® has discovered benefits in the more specific women’s health category of urinary incontinence, particularly stress induced urgency. Urinary incontinence is more pronounced in postpartum women as well as during menopause.
“There are a large number of women experiencing reduced quality of life due urinary incontinence. With these study results, Graminex is excited to present a natural alternative to help improve women’s lives during a time when it is needed most,” said Colleen May, CBO.
About Graminex® L.L.C.
Graminex® L.L.C. is the leading producer of natural and solvent-free Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 6,500 acres of farmland in Northwest Ohio to meet its customer’s needs. Graminex’s active ingredients are grown and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex® markets its own line of dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care.
For further information please contact Graminex®, L.L.C., Colleen May at +1 (419) 278-1023 or by e-mail at graminex@graminex.com. You may also visit www.graminex.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005211/en/
Contacts
Justin E Ritter
Regulatory Affairs
+1 (419) 278-1023
or
Colleen E. May
Chief Business Officer
+1 (419) 278-1023